| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745367 | Parkinsonism & Related Disorders | 2014 | 6 Pages |
Abstract
Our study confirms the long-term safety and efficacy of STN-DBS in PD. Nevertheless, the functionality of patients worsens over time, mainly for the onset and progression of levodopa-resistant and non-motor symptoms. The role of PD-subtype seems to be relevant in the long-term outcome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
M.G. Rizzone, A. Fasano, A. Daniele, M. Zibetti, A. Merola, L. Rizzi, C. Piano, C. Piccininni, L.M. Romito, L. Lopiano, A. Albanese,